CMPS COMPASS Pathways

$CMPS $DFTX $HELP I see a lot of newbies to small cap bio and impatient folks here. Welcome! We are set for a banger eoy. For those with stones these are gifts

$CMPS a green Friday is nice to see. If it stays who knows. We are still a long long way from where this should/will be. $40-50 is not unrealistic. I do hope the fda approval goes smoothly. They could very easily throw a wrench into the psychedelic sector by making the REMS extremely difficult. I hope that is not the case. There is no reason psilocybin and lsd should not be available for people who struggle with depression, anxiety and trauma. Yes need to be careful with specific people and backgrounds but that does the same for certain antidepressants and plenty of other medicines in this realm. Side effects are actually quite minimal with psychedelics. 🍄🚀

$CMPS I think next week is a reversal. A very big change in sentiment all over the internet. People are starting to find this one. Get in now while it’s low. Next thing you know $15 —-> $18 —-> $22 —-> $25+

$CMPS still absolutely blows my mind how this is below $2B while $DFTX sits comfortably above $5B. Again not attacking $DFTX but $CMPS should be significantly higher about 50%-100% higher.

$CMPS Don't discount the first mover/novelty hype cycle that propelled this to $59 in the beginning. It's all about to happen again with NDA submission and FDA approval.

$CMPS i feel like theres a massive mispricing gap in the market betwrrn cmps anf dftx? anybody see that or is just me

$CMPS just waiting for the day this magically is at $30 premarket or after hours. I know it’s coming.

$CMPS Psilocybin helped human cells live up to 57% longer in the laboratory and improved survival in aged mice. Researchers at Emory University and Baylor College of Medicine studied whether psilocybin might influence biological aging. Human fetal lung fibroblasts continuously exposed to 10 micromolar psilocin showed a 29% increase in cellular lifespan before reaching senescence — the point when cells stop dividing. At a higher concentration of 100 micromolar, their lifespan increased by 57%. Adult human skin fibroblasts treated with the same higher dose lived about 51% longer than untreated cells. Researchers then tested psilocybin in 19-month-old female mice, roughly comparable to older adulthood in humans. After monthly treatment for 10 months, 80% of the psilocybin-treated mice were still alive, compared with 50% of untreated control mice. 📃 RESEARCH PAPER 📌 Kato et al., “Psilocybin treatment extends cellular lifespan and improves survival of aged mice”, npj Aging (2025)

$CMPS $HELP SSRIs made me suicidal among other major side effects. Most people have major side effects from existing anti-depressants. Kind of the whole point with this emerging sector is that current treatments are a miss and we need a mental health treatment paradigm shift. I cannot for the life of me think of why anyone would remain on current treatment once better options are available (it's just that for many people, the only option is the best option) but it's good that Cybin is targeting that audience, because I'm sure they will exist in perpetuity in some capacity. At the end of the day, COMP360 is a monotherapy that has clear safety data for concurrent use with SSRIs targeting a different indication. This conversation is exhausting. I own both. P.S. - How many more "TRD" cases will pop up once we realize MDD and TRD are the same thing differentiated by patients' tolerance for side effects and limited efficacy given limited options?

$CMPS watching closely to add one last stack of shares before submission/approval. The herd still does not know/understand the whole story and remarkable opportunity this company’s molecule presents. Their trial structure, execution, outcomes and just as importantly compliance w FDA requirements was something every other company in the space will attempt to replicate. CMPS has set the standard. If you’re still unsure about this opp, you need to dig in.

$CMPS I mean if you look at the 6 month chart this thing is knocking and wants to move through. The lows keep coming but it’s bouncing back quicker and quicker. Ready for a rocket launch 🚀 It is undervalued and overlooked. I don’t think the market knows how to price something like this, is a paradigm shift. That don’t know what revenue will look like and going off of “normal” treatments and populations. TRD diagnosis and treatments are flying and again when you add PTSD to the mix this will be heavily taught after treatment. 🍄

$CMPS up down up down up down we gooo one day it will be up up and away 🍄🚀 don’t lose faith nothing has changed within this product, results or company

$CMPS For what it's worth...I feasted on Atai shares sub-$2 ...when retail morale was super low and emotions were running ultra-high...although I still feel that Atai management sold out much too low...trusting my due diligence and maintaining a rationale and realistic view of the company's assets/pipeline and overall value still generated a significant ROI on the Eli Lilly buy-out...I don't think a 4-5x ROI is in play here from the current SP...at least near-term...that will require actual sales support IMO...but 2-3x is definitely in play. GLTA.

$CMPS being a biotech investor is so brutal lol - tf does a diesel embargo have to do with us other than proving our president is an absolute fucking idiot ?

$CMPS Compass is visiting my office to conduct a site review tomorrow. I’ll start offering Comp360 next year :) This will ATH by Q2 2027 at the latest.

$CMPS algo selling. This is the final countdown. There’s no conviction to the downside, just a little sustained pressure maintaining minimal price action. Flipping Pennies hoping to take out some stops along the way.

$CMPS $HELP the goal is not to pit them against each other lol. $HELP has much more upside potential near term due to Phase 3 and then $CMPS regains the momentum and upside potential because as you say they are literally ready for commercial launch. Both are huge positives. Bullish on both, feel sorry for the short sellers but bad karma on them for shorting companies providing therapies that are sorely needed in this sector.

$CMPS look at FDA approved Spravato. This has been taken care of. Patients will walk into the same clinics that offer Spravato - this has already been thought out. Spravato did all the hard work. And there are also thousands of legal ketamine infusion clinics across the country. Once again, same model.

$CMPS CEO said the following during TD conference: ”There is clearly an extraordinarily unlikely scenario where we get approval and federal rescheduling by the end of this year, and that's why we have consistently said we would be launch-ready by the end of this year.” While its unlikely approval and rescheduling happen before year end, the only way it’s even a remote possibility is if they finalize the NDA submission in October. My guess is NDA submission will be finalized by Oct 15.

$CMPS I added today. I went outside today too. Went for a walk in the woods. It's my only way of seeing the color green at this point 😁